Correlation between circulating tumor cell levels and tumor response in patients with advanced hepatocellular carcinoma undergoing immunotherapy and molecular targeted therapy
Circulating tumor cells (CTCs) are closely associated with the progression of hepatocellular carcinoma (HCC). However, the clinical value of CTC detection in patients receiving systemic therapy for advanced HCC remains to be fully elucidated. A total of 125 patients with advanced HCC who underwent systemic therapy were...